High-throughput screening of saliva for early detection of oral cancer: A pilot study

Technology in Cancer Research and Treatment

Volumn 11, Issue 2, 2012, Pages 181-188

  Szanto, I ^a   Mark, L ^b   Bona, A ^b   Maasz, G ^b   Sandor, B ^a   Gelencser, G ^b   Turi, Z ^a   Gallyas, Jr ^b  

^a Univercsity of Pects Medictal Scthool   (Hungary)

^b Univercsity of Pects Medictal Scthool   (Hungary)

Author keywords

Annexin 1; Early diagnosis; High throughput analysis; MALDI TOF MS; Oral cancer; Peroxiredoxin 2; Saliva proteomics; Targeted peptide analysis

Indexed keywords

LIPOCORTIN 1; PEROXIREDOXIN 1; PEROXIREDOXIN 2; SALIVA PROTEIN; THIOREDOXIN PEROXIDASE; TUMOR MARKER; ANNEXIN; CYTOKERATIN 1; LIPOCORTIN 2; PROTEIN P53; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUTH CANCER; PEPTIDE ANALYSIS; PILOT STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SALIVA ANALYSIS; SEQUENCE HOMOLOGY; TANDEM MASS SPECTROMETRY; CANCER STAGING; CARCINOMA, MUCOEPIDERMOID; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; CHEMISTRY; COMPARATIVE STUDY; EARLY DIAGNOSIS; FOLLOW UP; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MOUTH NEOPLASMS; PROCEDURES; PROGNOSIS; PROTEOMICS; SALIVA; COLLISIONALLY ACTIVATED DISSOCIATION; COMPUTER MODEL; DNA FINGERPRINTING; DYSKERATOSIS; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, MUCOEPIDERMOID; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PILOT PROJECTS; PROGNOSIS; PROTEOMICS; SALIVA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84870714771     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500248     Document Type: Article

References (24)

1. Hu, S., Yu, T., Xie, Y., Yang, Y., Li, Y., Zhou, X., Tsung, S., Loo, R. R., Loo, J. R., Wong, D. T. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 4, 55-64 (2007).
2. Jemal, A., Siegel, R., Xu, J., Ward, E. Cancer statistics, CA Cancer J Clin 60, 277-300 (2010).[Crossref]
3. Khuri, F. R., Lee, J. J., Lippman, S. M., Kim, E. S., Cooper, J. S., Benner, S. E., Winn, R., Pajak, T. F., Williams, B., Shenouda, G., Hodson, I., Fu, K., Shin, D. M., Vokes, E. E., Feng, L., Goepfert, H., Hong, W. K. Randomized Phase III trial of low-dose isotretinoin for prevention of second primary tumours in stage I and II head and neck cancer patients. J Natl Cancer Inst 98, 441-450 (2006). [Crossref]
4. Gasparotto, D., Maestro, R. Molecular approaches to the staging of head and neck carcinomas (review). Int J Oncol 31, 175-180 (2007).
5. Weinberg, M. A., Estefan, D. J. Assessing oral malignancies. Am Fam Physician 65, 1379-1384 (2002).
6. Gonsalves, W. C., Chi, A. C., Neville, B. W. Common oral lesions: Part II. Masses and neoplasia. Am Fam Physician 75, 509-512 (2007).
7. Marocchio, L. S., Lima, J., Sperandio, F. F., Corrêa, L., de Sousa, S. O. Oral squamous cell carcinoma: an analysis of 1,564 cases showing advances in early detection. J Oral Sci 52, 267-273 (2010).
8. Maia, A. M., Barkokebas, A., Pires, A. P., Barros, L. F., Carvalho, A. A., Leão, J. C. Current use and future perspectives of diagnostic and therapeutic lasers in Oral Medicine. Minerva Stomatol 57, 511-517 (2008).
9. Mallia, R. J., Thomas, S. S., Mathews, A., Kumar, R., Sebastian, P., Madhavan, J., Subhash, N. Laser-induced autofluorescence spectral ratio reference standard for early discrimination of oral cancer. Cancer 112, 1503-1512 (2008). [Crossref]
10. Feuerstein, I., Najam-ul-Haq, M., Rainer, M., Trojer, L., Bakry, R., Aprilita, N. H., Stecher, G., Huck, C. W., Bonn, G. K., Klocker, H., Bartsch, G., Guttman, A. Material Enhanced Laser Desorption/Ionization (MELDI)-a new protein profiling tool utilizing specific carrier materials for TOF-MS Analysis. J Am Soc Mass Spectrom 17, 1203-1208 (2008). [Crossref]
11. Edgar, W. M. Saliva: its secretion, composition and functions. Br Dent J 172, 305-312 (1992).
12. Yao, Y., Berg, E. A., Costello, C. E., Troxler, R. F., Oppenheim, F. G. Identification of protein components in human acquired enamel pellicle and whole saliva using novel proteomics approaches. J Biol Chem 278, 5300-5308 (2003). [Crossref]
13. Drake, R. R., Cazare, L. H., Semmes, O. J., Wadsworth, J. T. Serum, salivary and tissue proteomics for discovery of biomarkers for head and cancers. Expert Rev Mol Diagn 5, 93-100 (2005). [Crossref]
14. Dale, B. A., Krisanaprakornkit, S. Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med 30, 321-327 (2001). [Crossref]
15. Caprioli, R. M. Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy. Cancer Res 65, 10642-10645 (2005).
16. Yarbrough, W. G., Slebos, R. J., Liebler, D. Proteomics: clinical applications for head and neck squamous cell carcinoma. Head Neck 28, 549-558 (2006). [Crossref]
17. Streckfus, C. F., Dubinsky, W. P. Proteomic analysis of saliva for cancer diagnosis. Expert Rev Proteomics 4, 329-332 (2007). [Crossref]
18. Xie, H., Onsongo, G., Popko, J., de Jong, E. P., Cao, J., Carlis, J. V., Griffin, R. J., Rhodus, N. L., Griffin, T. J. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics 7, 486-498 (2008). [Crossref]
19. de Jong, E. P., Xie, H., Onsongo, G., Stone, M. D., Chen, X. B., Kooren, J. A., Refsland, E. W., Griffin, R. J., Ondrey, F. G., Wu, B., Le, C. T., Rhodus, N. L., Carlis, J. V., Griffin, T. J. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One 5, e11148 (2010). [Crossref]
20. Xie, H., Rhodus, N. L., Griffin, R. J., Carlis, J. V., Griffin, T. J. A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol Cell Proteomics 4, 1826-1830 (2005). [Crossref]
21. Yan, W., Apweiler, R., Balgley, B. M., Boontheung, P., Bundy, J. L., Cargile, B. J., Cole, S., Fang, X., Gonzalez-Begne, M., Griffin, T. J., Hagen, F., Hu, S., Wolinsky, L. E., Lee, C. S., Malamud, D., Melvin, J. E., Menon, R., Mueller, M., Qiao, R., Rhodus, N. L., Sevinsky, J. R., States, D., Stephenson, J. L., Than, S., Yates, J. R., Yu, W., Xie, H., Xie, Y., Omenn, G. S., Loo, J. A., Wong, D. T. Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl 3, 116-134 (2009). [Crossref]
22. Ohshiro, K., Rosenthal, D. I., Koomen, J. M., Streckfus, C. F., Chambers, M., Kobayashi, R., El-Naggar, A. K. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int J Oncol 30, 743-749 (2007).
23. Yanagawa, T., Iwasa, S., Ishii, T., Tabuchi, K., Yusa, H., Onizawa, K., Omura, K., Harada, H., Suzuki, H., Yoshida, H. Peroxiredoxin I expression in oral cancer: a potential new tumour marker. Cancer Lett 156, 27-35 (2000). [Crossref]
24. Lin, C. Y., Jeng, Y. M., Chou, H. Y., Hsu, H. C., Yuan, R. H., Chiang, C. P., Kuo, M. Y. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J Surg Oncol 97, 544-550 (2008)